Form 4 holding
Former SVP, Clinical Development
Codiak BioSciences, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 87,411
- Estimated value
- Report date
- 08 Jun 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount